Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 412.5 GBX -1.43% Market Closed
Market Cap: 434.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Gross Margin
Oxford BioMedica PLC

36.7%
Current
49%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
36.7%
=
Gross Profit
35.7m
/
Revenue
97.3m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
UK
Oxford BioMedica PLC
LSE:OXB
434.4m GBP
37%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
US
Abbvie Inc
NYSE:ABBV
300.2B USD
67%
US
Amgen Inc
NASDAQ:AMGN
158.7B USD
60%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.8B USD
86%
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD
78%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
AU
CSL Ltd
ASX:CSL
137.3B AUD
52%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.3B USD
87%
US
Seagen Inc
F:SGT
39.3B EUR
75%
NL
argenx SE
XBRU:ARGX
34.1B EUR
89%
Country UK
Market Cap 434.4m GBP
Gross Margin
37%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 300.2B USD
Gross Margin
67%
Country US
Market Cap 158.7B USD
Gross Margin
60%
Country US
Market Cap 126.8B USD
Gross Margin
86%
Country US
Market Cap 114.8B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 137.3B AUD
Gross Margin
52%
Country US
Market Cap 88.3B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.1B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for Oxford BioMedica PLC.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
36.7%
=
Gross Profit
35.7m
/
Revenue
97.3m
What is the Gross Margin of Oxford BioMedica PLC?

Based on Oxford BioMedica PLC's most recent financial statements, the company has Gross Margin of 36.7%.